National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 7149-7150 [2025-01330]
Download as PDF
<![CDATA[
Federal Register / Vol. 90, No. 12 / Tuesday, January 21, 2025 / Notices
ddrumheller on DSK120RN23PROD with NOTICES1
acquisitions or contracts; (6) manages
the Agency’s acquisition workforce
training and certification programs; (7)
manages the IHS Contract Information
System and controls entry of data into
HHS Contract Information System; (8)
serves as the IHS contact point for
contract protests and HHS contact for
contract-related issues; (9) oversees and
implements the agency’s contract
planning, solicitation, review,
negotiation, award, post-award
administration, and contract closeout
activities; (10) processes unsolicited
proposals for the IHS; (11) coordinates
the IHS Small Business programs; (12)
oversees compliance with the Buy
Indian Act; (13) manages the Agency’s
Government Purchase Card (GPC)
program; and (14) manages and oversees
compliance and oversight of all
acquisition operations activities within
the Agency.
Division of Grants Management (DGM)
(GALD)
(1) Directs grants management and
operations for the IHS; (2) authorizes,
awards and administers discretionary
grants and cooperative agreements for
IHS financial assistance programs; (3)
provides guidance for the resolution of
audit findings for grant programs; (4)
manages the IHS grants training and
certification program; (5) continuously
assesses grants operations; (6) oversees
implementation of corrective action
plans for recipients receiving IHS
discretionary grant support; (7) reviews
and makes recommendations for
improvements in current grantee and
potential grantee management systems;
(8) serves as the IHS liaison to HHS
Office of Grants and the public for
discretionary grants and cooperative
agreements authorized by the IHS; (9)
maintains the SAM.gov Assistance
Listings (formerly the Catalog of Federal
Domestic Assistance) for IHS financial
assistance programs; (10) provides
guidance technical assistance, grantsrelated training and assistance for IHS
staff, grantees, and applicants; (11)
liaison to the HHS Quality Service
Management Office (QSMO) for Grants;
(12) controls data entry into the grant
award system; (13) maintains the
official, electronic grant files for funded
grants and controls data entry into the
grant award system; (14) maintains the
official, electronic grant files for funded
grants; (15) coordinates payment to
scholarship recipients in coordination
with the Division of Health Professions
Support Office of Human Resources;
(16) manages the clearance and approval
process for all IHS grant funding notices
in Grants.gov; and (17) reviews and
coordinates inter- and intra-agency
VerDate Sep<11>2014
19:56 Jan 18, 2025
Jkt 265001
agreements as well as Memoranda of
Understanding in collaboration with HQ
Offices.
Division of Regulatory and Policy
Coordination (DRPC) (GALE)
(1) Manages the IHS’s overall
regulations program and
responsibilities, including determining
the need for and developing plans for
changes in regulations, developing or
assuring the development of needed
regulations, and maintaining the various
regulatory planning processes; (2) serves
as IHS liaison with the Office of the
Federal Register (FR) on matters relating
to the submission and clearance of
documents for publication in the FR; (3)
assures proper Agency clearance and
processing of FR documents; (4) informs
management and program officials of
regulatory activities of other Federal
agencies; (5) advises the OMS Director
on such matters as regulations, related
policy issues, and administrative
support issues; (6) manages the retrieval
and transmittal of information in
response to requests received under the
FOIA, in collaboration with the Public
Affairs Staff; (7) coordinates with Office
of General Counsel (OGC) to determine
disclosure or deny release of IHS
records under FOIA; (8) coordinates
requests for information with the Area
FOIA coordinators; (9) identifies and
informs the IHS Privacy Officer of FOIA
related difficulties across the IHS; (10)
ensures the security of sensitive and/or
confidential information when
responding to FOIA issues; (11)
researches and applies legal
determinations to respond requests and
releasable material; (12) maintains and
updates various regulatory agendas; (13)
formulates, administers, and supports
IHS-wide policies, delegations of
authority, and organizations and
functions development; (14) provides
leadership, on behalf of the IHS
Director, to functional area managers at
IHS HQ in developing, modifying, and
overseeing the implementation of IHS
policies and procedures; (15) provides
analysis, advisory, and assistance
services to IHS managers and staff for
the development, clearance, and filing
of IHS directives and delegations of
authority; (16) serves as principal
advisor and source for technical
assistance for establishment or
modification of organizational
infrastructures, functions, and Standard
Administrative Code configurations;
(17) advises the IHS Director and serves
as liaison with OGC on such matters as
litigation, regulation, related policy
issues, and administrative support
issues; and (18) ensures the security of
sensitive and/or confidential
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
7149
information when responding to FOIA
and other regulatory issues.
Section GA–40, Indian Health Service—
Delegations of Authority
All delegations of authority and redelegations of authority made to IHS
officials that were in effect immediately
prior to this reorganization, and that are
consistent with this reorganization,
shall continue in effect pending further
re-delegation.
Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2025–00535 Filed 1–17–25; 8:45 am]
BILLING CODE 4166–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The contract proposals and
grant applications the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the contract proposals, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Phase 1 Clinical Trial
Contract Review.
Date: February 10, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Address: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Joel A Saydoff, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH/DHHS, NSC, 6001 Executive
Boulevard, Rockville, MD 20852, 301–496–
9223 joel.saydoff@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group Neurological Sciences and
Disorders A Study Section NSD–A Review
Meeting.
Date: February 13–14, 2025.
Time: 9:00 a.m. to 3:00 p.m.
E:\FR\FM\21JAN1.SGM
21JAN1
7150
Federal Register / Vol. 90, No. 12 / Tuesday, January 21, 2025 / Notices
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Natalia Strunnikova,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Activities, NINDS/NIH/DHHS, NSC, 6001
Executive Boulevard, Rockville, MD 20852,
301–402–0288 natalia.strunnikova@nih.gov.
Maryland, 20850 which was published
in the Federal Register on December 26,
2024, FR Doc 2024–30711, 89 FR
105062.
This notice is being amended to
change the virtual meeting date from
March 03, 2025, 11 a.m. to 4 p.m. to
March 4, 2025, 11 a.m. to 4 p.m. The
meeting times, format, and location will
stay the same. The meeting is closed to
the public.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: January 14, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
Dated: January 14, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2025–01328 Filed 1–17–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
[FR Doc. 2025–01330 Filed 1–17–25; 8:45 am]
Fish and Wildlife Service
BILLING CODE 4140–01–P
[FWS–R3–ES–2024–N074;
FXES11130300000–245–FF03E00000]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Endangered and Threatened Species;
Receipt of Recovery Permit
Applications
National Institutes of Health
National Human Genome Research
Institute; Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Council for Human Genome Research,
February 10, 2025, 9 a.m. to February
11, 2025, 5 p.m., National Institutes of
Health, Capital Gateway Building,
6700B Rockledge Drive, Room 1100,
Bethesda, MD 20892 which was
published in the Federal Register on
January 10, 2025, 90 FR 2710.
Amendment to change the start time
of the open session from 10 a.m. to
11:30 a.m. The meeting is partially
closed to the public.
Dated: January 14, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
Fish and Wildlife Service,
Interior.
ACTION: Notice of receipt of permit
applications; request for comments.
AGENCY:
We, the U.S. Fish and
Wildlife Service, have received
applications for permits to conduct
scientific research to promote
conservation or other activities intended
to enhance the propagation or survival
of endangered or threatened species
under the Endangered Species Act. We
invite the public and local, State, Tribal,
and Federal agencies to comment on
these applications. Before issuing any of
the requested permits, we will take into
consideration any information that we
receive during the public comment
period.
SUMMARY:
We must receive your written
comments on or before February 20,
2025.
DATES:
[FR Doc. 2025–01327 Filed 1–17–25; 8:45 am]
BILLING CODE 4140–01–P
Document availability and
comment submission: Submit requests
for copies of the applications and
related documents, as well as any
comments, by one of the following
methods. All requests and comments
should specify the applicant name(s)
and application number(s) (e.g.,
ESXXXXXX; see table in
SUPPLEMENTARY INFORMATION).
• Email (preferred method):
permitsR3ES@fws.gov. Please refer to
the respective application number (e.g.,
Application No. ESXXXXXX) in the
subject line of your email message.
ADDRESSES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ddrumheller on DSK120RN23PROD with NOTICES1
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, TEP–
5A: SBIR Review Meeting, March 3,
2025, 11 a.m. to 4 p.m., National Cancer
Institute Shady Grove, 9609 Medical
Center Drive, Room 7W534, Rockville,
VerDate Sep<11>2014
19:56 Jan 18, 2025
Jkt 265001
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
• U.S. Mail: Regional Director, Attn:
Nathan Rathbun, U.S. Fish and Wildlife
Service, Ecological Services, 5600
American Blvd. West, Suite 990,
Bloomington, MN 55437–1458.
FOR FURTHER INFORMATION CONTACT:
Nathan Rathbun, 612–713–5343
(phone); permitsR3ES@fws.gov (email).
Individuals in the United States who are
deaf, deafblind, hard of hearing, or have
a speech disability may dial 711 (TTY,
TDD, or TeleBraille) to access
telecommunications relay services.
Individuals outside the United States
should use the relay services offered
within their country to make
international calls to the point-ofcontact in the United States.
SUPPLEMENTARY INFORMATION: We, the
U.S. Fish and Wildlife Service, invite
review and comment from the public
and local, State, Tribal, and Federal
agencies on applications we have
received for permits to conduct certain
activities with endangered and
threatened species under section
10(a)(1)(A) of the Endangered Species
Act of 1973, as amended (ESA; 16
U.S.C. 1531 et seq.), and our regulations
in the Code of Federal Regulations
(CFR) at 50 CFR part 17. Documents and
other information submitted with the
applications are available for review,
subject to the requirements of the
Privacy Act and the Freedom of
Information Act.
Background
The ESA prohibits certain activities
with endangered and threatened species
unless authorized by a Federal permit.
The ESA and our implementing
regulations in part 17 of title 50 of the
Code of Federal Regulations (CFR)
provide for the issuance of such permits
and require that we invite public
comment before issuing permits for
activities involving endangered species.
A recovery permit issued by us under
section 10(a)(1)(A) of the ESA
authorizes the permittee to conduct
activities with endangered species for
scientific purposes that promote
recovery or for enhancement of
propagation or survival of the species.
Our regulations implementing section
10(a)(1)(A) for these permits are found
at 50 CFR 17.22 for endangered wildlife
species, 50 CFR 17.32 for threatened
wildlife species, 50 CFR 17.62 for
endangered plant species, and 50 CFR
17.72 for threatened plant species.
Permit Applications Available for
Review and Comment
The ESA requires that we invite
public comment before issuing these
permits. Accordingly, we invite local,
E:\FR\FM\21JAN1.SGM
21JAN1
]]>Agencies
[Federal Register Volume 90, Number 12 (Tuesday, January 21, 2025)]
[Notices]
[Pages 7149-7150]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-01330]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The contract proposals and grant applications the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the contract proposals, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel; Phase 1 Clinical Trial Contract
Review.
Date: February 10, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Address: National Institutes of Health, Neuroscience Center,
6001 Executive Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Joel A Saydoff, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH/DHHS, NSC, 6001 Executive Boulevard,
Rockville, MD 20852, 301-496-9223 [email protected].
Name of Committee: National Institute of Neurological Disorders
and Stroke Initial Review Group Neurological Sciences and Disorders
A Study Section NSD-A Review Meeting.
Date: February 13-14, 2025.
Time: 9:00 a.m. to 3:00 p.m.
[[Page 7150]]
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Neuroscience Center,
6001 Executive Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Natalia Strunnikova, Ph.D., Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, NINDS/NIH/DHHS, NSC, 6001 Executive Boulevard,
Rockville, MD 20852, 301-402-0288 [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: January 14, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2025-01330 Filed 1-17-25; 8:45 am]
BILLING CODE 4140-01-P
